148 results on '"J.E. Lee"'
Search Results
2. P146 Risk factors of breast cancer recurrence in pathologic complete response achieved patients following neoadjuvant chemotherapy
3. Clinical presentation, hormonal profiles in nulliparous Korean women with polycystic ovarian morphology
4. Margins and outcomes in breast conserving surgery after neoadjuvant chemotherapy treated with whole breast radiation
5. Surgical and oncologic outcomes of robotic and conventional nipple-sparing mastectomy with immediate reconstruction: pooled analysis of individual patient-level data from international multi-centers
6. Protective mechanism of agmatine pretreatment on RGC-5 cells injured by oxidative stress
7. PP01.19 Volatile Organic Compound Biomarkers Identification for Prediction of Lung Cancer Based on Exhaled Breath Analysis
8. 24P Efficacy and safety of 1st generation EGFR TKI retreatment in EGFR mutation-positive, T790M-negative patients previously treated with 1st or 2nd generation EGFR TKI and cytotoxic chemotherapy
9. OD2-6 CDK9 serves as the potent therapeutic target in tamoxifen-resistant breast cancer cells
10. PP015 Vitis vinifera seed extract prevents tumorigenesis through interleukin-1 alpha in triple-negative breast cancer models
11. PP014 Entelon improves trastuzumab resistance through inhibiting FN1 expression in HER2-positive breast cancers
12. EP08.02-142 Effects of Afatinib on the Treatment and Prognosis of Brain Metastasis in Advanced EGFR Mutation (+) NSCLC
13. 968TiP A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation positive non-small cell lung cancer (stage III) who have not progressed following definitive, platinum-based, chemoradiation therapy (PLATINUM trial)
14. EP08.01-017 Evaluation of Blood Tumor Mutation Burden for Efficacy of Second- Line Atezolizumab Treatment in Non-small Cell Lung Cancer
15. 1085P Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY
16. W054 Suggestion of cystatin C indication using muscle mass-based parameter for the desirable prediction of glomerular filtration rate
17. W169 Serum vitamin profile and its relationship with other biomarkers in Korean breast cancer patients
18. W208 Association of blood cadmium concentration with dyslipidemia in the general population of Korea
19. Surgical and oncologic outcomes of robotic and conventional nipple-sparing mastectomy with immediate reconstruction: pooled analysis of individual patient-level data from international multi-centers
20. Margins and outcomes in breast conserving surgery after neoadjuvant chemotherapy treated with whole breast radiation
21. Prognostic Significance of Preoperative and Postoperative CA 19-9 Normalization in Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy or Surgery First
22. Validation of practice-specific drain fluid amylase cutoffs following pancreaticoduodenectomy in risk-stratified pancreatectomy care pathways
23. Common and Uncommon Features of Central Nervous System Lymphoma on Traditional and Advanced Imaging Modalities
24. Neoadjuvant Treatment Mitigates the Survival Impact of Major Complications after Resection of Pancreatic Adenocarcinoma
25. Response to and Survival after First-Line FOLFIRINOX or Gemcitabine/Nab-Paclitaxel for Localized Pancreatic Ductal Adenocarcinoma
26. Incidence of postoperative complications following pancreatectomy for mucinous cystic lesions versus pancreatic cancer
27. Neighborhood-level socioeconomic status and outcomes in patients with localized pancreatic adenocarcinoma treated with first-line FOLFIRINOX
28. Survival impact of incidence of lymph node metastases and radical resection for duodenal neuroendocrine tumors: analyses of the national cancer database 2004-2016
29. Prognostic role of breast pathologic complete response after neoadjuvant chemotherapy in node-positive breast cancer patients
30. SUN-257 COMPARISON OF DIFFERENT METHODS OF NORMALIZING SKELETAL MUSCLE MASS TO DIAGNOSE SARCOPENIA AMONG HEMODIALYSIS PATIENTS
31. Baseline CA19-9 at diagnosis stratifies prognosis in patients with resected pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery-first sequencing
32. Neoadjuvant Treatment Mitigates The Survival Impact Of Major Complications After Resection Of Pancreatic Adenocarcinoma
33. A randomized controlled trial of botulinum toxin for treating sleep bruxism: a polysomnographic evaluation
34. SUN-072 PROGNOSTIC VALUE OF SOLUBLE ST2 AND SOLUBLE LR11 ON MORTALITY AND CARDIOVASCULAR EVENT IN PERITONEAL DIALYSIS PATIENTS
35. PO-0829 MRI-based texture analysis of lymph node for predicting clinical outcome in cervical cancer patients
36. Risk-stratified use of perioperative pasireotide does not decrease post-operative pancreatic fistula in high-risk pancreatectomy patients
37. Early postoperative drain fluid amylase in risk-stratified patients: Implications for tailored post-pancreatectomy drain management
38. Defining risk factors and outcomes in 537 patients with simultaneous liver and pancreas resection
39. Neurofilament Subunits are Integral Components of Synapses and Modulate Neurotransmission and Behavior In Vivo
40. Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium
41. Initial Report of the Korean Organ Transplant Registry: The First Report of National Kidney Transplantation Data
42. P3.13-29 Patient-Derived Xenograft Models(PDX) of Lung Squamous Cell Carcinoma(SCC) for Preclinical Studies
43. Reducing cost of hospitalization with risk stratified post-pancreatectomy clinical pathways at a single high-volume institution
44. The impact of tumor differentiation on perioperative outcomes and patterns of recurrence following preoperative therapy for resectable pancreatic adenocarcinoma
45. Clinical value of cardiac troponin detected at emergency room in patients undergoing emergent CABG
46. EP-1140: Hypofractionated radiotherapy for early glottic cancer: retrospective analysis of single institution
47. EP-1121: Treatment of oral cavity cancer: concurrent chemoradiotherapy vs surgery followed by radiotherapy
48. Impact of perioperative blood transfusions on survival in patients with borderline resectable pancreatic adenocarcinoma after neoadjuvant therapy
49. PT01.1: The Effects of Applying Gastric Residual Volume Management Protocol(GRVMP) in Critically Ill Patients
50. SAT-065 LOW NATURAL KILLER CELL ACTIVITY MAY CONTRIBUTE TO DEVELOPMENT OF SARCOPENIA IN HEMODIALYSIS PATIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.